These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 18515468

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tardive dystonic symptoms associated with aripiprazole treatment.
    Lim HK, Pae CU, Lee C, Lee CU.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):589-90. PubMed ID: 18053627
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Suppression of antipsychotic-induced tardive dyskinesia with aripiprazole in an elderly patient with bipolar I disorder.
    Wu WY, Chan HY, Tan HK.
    Acta Neuropsychiatr; 2014 Feb 15; 26(1):61-4. PubMed ID: 25142102
    [Abstract] [Full Text] [Related]

  • 7. Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
    Rajarethinam R, Dziuba J, Manji S, Pizzuti A, Lachover L, Keshavan M.
    World J Biol Psychiatry; 2009 Feb 15; 10(4 Pt 2):416-9. PubMed ID: 19492247
    [Abstract] [Full Text] [Related]

  • 8. High dosage of aripiprazole-induced dysphagia.
    Lin TW, Lee BS, Liao YC, Chiu NY, Hsu WY.
    Int J Eat Disord; 2012 Mar 15; 45(2):305-6. PubMed ID: 21541978
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low-dose manic switch and high-dose antimanic effect and extrapyramidal symptoms by aripiprazole in a single bipolar patient.
    Park YM.
    Am J Ther; 2014 Mar 15; 21(6):e218-20. PubMed ID: 23676345
    [Abstract] [Full Text] [Related]

  • 12. Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders.
    Gupta S, Masand P.
    Ann Clin Psychiatry; 2004 Mar 15; 16(3):155-66. PubMed ID: 15517848
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immediate versus gradual suspension of previous treatments during switch to aripiprazole: results of a randomized, open label study.
    Pae CU, Serretti A, Chiesa A, Mandelli L, Lee C, Lee C, Kim J, De Ronchi D, Paik IH.
    Eur Neuropsychopharmacol; 2009 Aug 15; 19(8):562-70. PubMed ID: 19442491
    [Abstract] [Full Text] [Related]

  • 17. Covert dyskinesia associated with aripiprazole: a case report and review of the literature.
    Moseley CN, Simpson-Khanna HA, Catalano G, Catalano MC.
    Clin Neuropharmacol; 2013 Aug 15; 36(4):128-30. PubMed ID: 23860346
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.
    Adan-Manes J, Garcia-Parajua P.
    J Clin Pharm Ther; 2009 Apr 15; 34(2):245-6. PubMed ID: 19250146
    [Abstract] [Full Text] [Related]

  • 20. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Stip E, Tourjman V.
    Clin Ther; 2010 Apr 15; 32 Suppl 1():S3-20. PubMed ID: 20152550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.